Your browser doesn't support javascript.
loading
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Quaglino, Pietro; Ascierto, Paolo A; Consoli, Francesca; Queirolo, Paola; Spagnolo, Francesco; Morelli, Maria Francesca; Berardi, Rossana; Chiarion-Sileni, Vanna; Tucci, Marco; Troiani, Teresa; Melotti, Barbara; Rossi, Ernesto; Mandala, Mario; Rinaldi, Gaetana; Marcon, Ilaria Gioia; Pizzuti, Matteo; Del Vecchio, Michele.
Afiliación
  • Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
  • Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Consoli F; Department of Oncology, ASST Spedali Civili, Brescia, Italy.
  • Queirolo P; Oncology Division, Policlinico San Martino IRCCS, Genova, Italy, and Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Spagnolo F; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Morelli MF; Department of Oncology and Dermatological Oncology, Istituto Dermopatico dell'Immacola, Rome, Italy.
  • Berardi R; Università Politecnica delle Marche - Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Tucci M; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Bari, Italy.
  • Troiani T; Faculty of Medicine, Second University of Naples, Naples, Italy.
  • Melotti B; Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Rossi E; Medical Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Mandala M; Division of Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy, and University of Perugia, Perugia, Italy.
  • Rinaldi G; UOC Oncologia Medica Aoup Paolo Giaccone, Palermo, Italy.
  • Marcon IG; Novartis Farma S.p.A, Milan, Italy.
  • Pizzuti M; Novartis Farma S.p.A, Milan, Italy.
  • Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cancer Manag Res ; 15: 1271-1281, 2023.
Article en En | MEDLINE | ID: mdl-38027240
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2023 Tipo del documento: Article País de afiliación: Italia